Intended Use of Biomarkers and Diagnostic Tests for MASH
Mapping 12 blood, imaging, and composite diagnostic tools to their primary clinical applications and required data inputs.
If you're wondering why your doctor ordered two or three different tests instead of just one, this chart shows how the pieces fit together. Tests at the top (FIB-4 and SAFE) act as an early triage screen, middle groups measure either liver fat or scar stiffness individually, and the bottom group assesses both fat and scarring together.
Test-Type Legend
| Intended Use | Biomarker / Diagnostic Test | Test Type Components |
|---|---|---|
| Referral / risk stratification | FIB-41-4 | |
| SAFE score5 | ||
| Steatosis assessment only | Ultrasound attenuation6 | |
| MRI-PDFF3 | ||
| Fibrosis assessment only | ELF™1,2 | |
| US-based elastography1,7 | ||
| MRE2 | ||
| Agile 3+ / Agile 48 | ||
| Steatosis and fibrosis assessment | NASH-FibroSure® / FibroTest™9-11 | |
| LiverMultiScan12 | ||
| FAST13,14 | ||
| MAST14 |